Efficacy and immunogenicity of Mycobacterium bovis DeltaRD1 against aerosol M. bovis infection in neonatal calves
about
The Case for Live Attenuated Vaccines against the Neglected Zoonotic Diseases Brucellosis and Bovine TuberculosisMycobacterium bovis Infection of Cattle and White-Tailed Deer: Translational Research of Relevance to Human TuberculosisSignal regulatory protein alpha (SIRPalpha) cells in the adaptive response to ESAT-6/CFP-10 protein of tuberculous mycobacteria.Use of fecal volatile organic compound analysis to discriminate between non-vaccinated and BCG-Vaccinated cattle prior to and after Mycobacterium bovis challenge.Revaccination of cattle with bacille Calmette-Guérin two years after first vaccination when immunity has waned, boosted protection against challenge with Mycobacterium bovis.Field evaluation of the efficacy of Mycobacterium bovis bacillus Calmette-Guerin against bovine tuberculosis in neonatal calves in Ethiopia.Tuberculosis immunity: opportunities from studies with cattleTALE nickase-mediated SP110 knockin endows cattle with increased resistance to tuberculosis.Identification of surrogates and correlates of protection in protective immunity against Mycobacterium bovis infection induced in neonatal calves by vaccination with M. bovis BCG Pasteur and M. bovis BCG Danish.Coresistance to isoniazid and ethionamide maps to mycothiol biosynthetic genes in Mycobacterium bovis.Characterization of effector and memory T cell subsets in the immune response to bovine tuberculosis in cattle.Application of Long-term cultured Interferon-γ Enzyme-linked Immunospot Assay for Assessing Effector and Memory T Cell Responses in Cattle.A recombinant attenuated Mycobacterium tuberculosis vaccine strain is safe in immunosuppressed simian immunodeficiency virus-infected infant macaquesDifferential Cytokine Gene Expression in Granulomas from Lungs and Lymph Nodes of Cattle Experimentally Infected with Aerosolized Mycobacterium bovisInterleukin-17A as a Biomarker for Bovine TuberculosisViral booster vaccines improve Mycobacterium bovis BCG-induced protection against bovine tuberculosis.Increased TNF-α/IFN-γ/IL-2 and Decreased TNF-α/IFN-γ Production by Central Memory T Cells Are Associated with Protective Responses against Bovine Tuberculosis Following BCG Vaccination.Recombinant vaccines and the development of new vaccine strategies.Clinical and diagnostic developments of a gamma interferon release assay for use in bovine tuberculosis control programs.A neonatal oral Mycobacterium tuberculosis-SIV prime / intramuscular MVA-SIV boost combination vaccine induces both SIV and Mtb-specific immune responses in infant macaques.DIVA reagents for bovine tuberculosis vaccines in cattle.Overview of vaccination trials for control of tuberculosis in cattle, wildlife and humans.A human challenge model for Mycobacterium tuberculosis using Mycobacterium bovis bacille Calmette-Guerin.Adjuvants induce distinct immunological phenotypes in a bovine tuberculosis vaccine model.Bacillus Calmette-Guérin vaccination reduces the severity and progression of tuberculosis in badgers.
P2860
Q26740410-9F7ACEE6-715A-49ED-831A-8164EDDBDBDDQ28083909-E6EFDBE7-3AFE-4931-8E40-AFD05CB97758Q33488555-17F198CF-46E4-4E64-A958-D893DB9578D7Q33883795-A822C6A1-D21D-4234-8E28-06A9A1F2C1EBQ34122572-E6601D55-8B80-415E-84B4-2DFF08D7EA99Q34190004-4286C79C-0EA9-4FA8-A04A-D7C16C6FCBBDQ34416986-6EF19D90-85D7-4DB9-A183-50B8B4F129F1Q34465379-0D08182F-5E68-4002-9B2F-BADBDC56763BQ34739101-BA7DEC33-5C03-4713-9620-A7D443BC2CCCQ35191397-17E085A0-3120-49B0-BC4F-E02426249EA7Q35448351-74D3A08B-04B7-4BF5-B287-C9735E69C277Q35982511-5143CCE5-7A19-4411-80F6-3DD3C2B90FB0Q36154750-282DD95B-F17F-4316-817F-92E1597F878FQ36208320-64B278C8-A391-44BC-BAE6-43A2117C3E2FQ36555072-250A5523-34A2-4432-98FD-708C8ED29640Q37274874-8B065F33-331B-4550-81CF-B7C4D86BA8D2Q37342751-95EB53DC-B78F-4E8F-ABC3-8DABC086BC4CQ37370940-E71D283C-4664-4FD8-B4F4-87D3A2D19026Q37469326-6D4BCE8E-5E17-4B5A-A18F-A50608A6E634Q37490057-F30F44D6-FD53-42CF-AF64-174B73713EAAQ37909428-068154F1-A79F-43B1-835C-AA466D7D23B6Q38156497-733BE57B-B924-4115-AD42-C94FD94FB78DQ42018546-EA4C8127-F227-41C0-B336-097F5A067A72Q42576378-357AD3EB-8B62-43CF-A10B-BEDEEBFE9004Q54394183-267EE9D4-F95A-4D98-BB36-7E22D9449511
P2860
Efficacy and immunogenicity of Mycobacterium bovis DeltaRD1 against aerosol M. bovis infection in neonatal calves
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 09 January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Efficacy and immunogenicity of ...... s infection in neonatal calves
@en
Efficacy and immunogenicity of ...... infection in neonatal calves.
@nl
type
label
Efficacy and immunogenicity of ...... s infection in neonatal calves
@en
Efficacy and immunogenicity of ...... infection in neonatal calves.
@nl
prefLabel
Efficacy and immunogenicity of ...... s infection in neonatal calves
@en
Efficacy and immunogenicity of ...... infection in neonatal calves.
@nl
P2093
P2860
P50
P1433
P1476
Efficacy and immunogenicity of ...... s infection in neonatal calves
@en
P2093
Brian J Nonnecke
Charles F Capinos Scherer
D Mark Estes
Glenn C Federe
H Martin Vordermeier
John R Walker
Karolin Biermann
Michelle H Larsen
Mitchell V Palmer
R Glyn Hewinson
P2860
P304
P356
10.1016/J.VACCINE.2008.12.018
P407
P577
2009-01-09T00:00:00Z